Iodine-131Epiphora and nasolacrimal duct obstruction: 3 case reports

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-017-29146-9
中图分类号
学科分类号
摘要
引用
收藏
页码:167 / 167
相关论文
共 50 条
  • [3] Nasolacrimal duct obstruction as an important cause of epiphora
    Avdagic, Ema
    Phelps, Paul O.
    [J]. DM DISEASE-A-MONTH, 2020, 66 (10):
  • [5] Differentiated Thyroid Cancer With Epiphora Detection of Nasolacrimal Duct Obstruction on I-131 SPECT/CT
    Yuoness, Salem
    Rachinsky, Irina
    Driedger, Albert A.
    Belhocine, Tarik Z.
    [J]. CLINICAL NUCLEAR MEDICINE, 2011, 36 (12) : 1149 - 1152
  • [6] Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction
    Girard, B.
    Piaton, J. -M.
    Keller, P.
    Abadie, C.
    Nguyen, T. H.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2017, 40 (08): : 661 - 665
  • [7] Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer
    Fard-Esfahani, Armaghan
    Farzanefar, Saeed
    Fallahi, Babak
    Beiki, Davood
    Saghari, Mohsen
    Emami-Ardekani, Alireza
    Majdi, Mina
    Eftekhari, Mohammad
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (10) : 1077 - 1080
  • [8] Nasolacrimal Duct Obstruction as a Complication of Iodine-131 Therapy in Patients with Thyroid Cancer
    Fard-Esfahani, A.
    Farzanefar, S.
    Fallahi, B.
    Beiki, D.
    Eftekhari, M.
    Saghari, M.
    Emamiardekani, A.
    Majdi, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S346 - S346
  • [9] Nasolacrimal Duct Obstruction as a Complication of Iodine-131 Therapy in Patients with Thyroid Cancer
    Fard-Esfahani, A.
    Farzanefar, S.
    Fallahi, B.
    Beiki, D.
    Eftekhari, M.
    Saghari, M.
    Emamiardekani, A.
    Majdi, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S410 - S410